Renaissance Technologies’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,905
Closed -$23.6K 4025
2024
Q3
$23.6K Buy
17,905
+700
+4% +$924 ﹤0.01% 3419
2024
Q2
$131K Buy
17,205
+300
+2% +$2.28K ﹤0.01% 3134
2024
Q1
$152K Buy
16,905
+545
+3% +$4.9K ﹤0.01% 3287
2023
Q4
$175K Buy
16,360
+695
+4% +$7.43K ﹤0.01% 3176
2023
Q3
$94K Buy
15,665
+1,315
+9% +$7.89K ﹤0.01% 3263
2023
Q2
$99K Buy
14,350
+1,595
+13% +$11K ﹤0.01% 3480
2023
Q1
$200K Buy
12,755
+665
+6% +$10.4K ﹤0.01% 3281
2022
Q4
$242K Sell
12,090
-36,900
-75% -$739K ﹤0.01% 3331
2022
Q3
$874K Buy
48,990
+16,803
+52% +$300K ﹤0.01% 2578
2022
Q2
$715K Buy
32,187
+4,997
+18% +$111K ﹤0.01% 2925
2022
Q1
$756K Buy
27,190
+8,363
+44% +$233K ﹤0.01% 2910
2021
Q4
$855K Buy
18,827
+11,687
+164% +$531K ﹤0.01% 2765
2021
Q3
$595K Buy
7,140
+4,530
+174% +$378K ﹤0.01% 2817
2021
Q2
$248K Buy
+2,610
New +$248K ﹤0.01% 3200
2021
Q1
Sell
-4,928
Closed -$483K 3816
2020
Q4
$483K Sell
4,928
-2,456
-33% -$241K ﹤0.01% 2835
2020
Q3
$251K Buy
7,384
+3,982
+117% +$135K ﹤0.01% 3054
2020
Q2
$193K Buy
3,402
+2,036
+149% +$116K ﹤0.01% 3172
2020
Q1
$80K Buy
1,366
+317
+30% +$18.6K ﹤0.01% 3263
2019
Q4
$83K Buy
+1,049
New +$83K ﹤0.01% 3341
2019
Q2
Sell
-1,677
Closed -$282K 3804
2019
Q1
$282K Buy
+1,677
New +$282K ﹤0.01% 3112
2018
Q3
Sell
-548
Closed -$1.17M 3620
2018
Q2
$1.17M Buy
548
+25
+5% +$53.6K ﹤0.01% 2537
2018
Q1
$1.3M Buy
+523
New +$1.3M ﹤0.01% 2539
2016
Q4
Sell
-52
Closed -$57K 3523
2016
Q3
$57K Buy
+52
New +$57K ﹤0.01% 3245
2014
Q1
Sell
-13
Closed -$30K 3062
2013
Q4
$30K Buy
+13
New +$30K ﹤0.01% 2803
2013
Q3
Sell
-38
Closed -$356K 2983
2013
Q2
$356K Buy
+38
New +$356K ﹤0.01% 2351